Growth Metrics

Harmony Biosciences Holdings (HRMY) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $7000.0.

  • Harmony Biosciences Holdings' Depreciation & Amortization (CF) changed 0.0% to $7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $26000.0, marking a year-over-year decrease of 9388.24%. This contributed to the annual value of $267000.0 for FY2024, which is 4805.45% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Depreciation & Amortization (CF) of $7000.0 as of Q3 2025, which was down 0.0% from $6000.0 recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Depreciation & Amortization (CF) high stood at $164000.0 for Q4 2023, and its period low was $6000.0 during Q4 2024.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $100000.0 (2021), whereas its average is $86105.3.
  • Over the last 5 years, Harmony Biosciences Holdings' Depreciation & Amortization (CF) had its largest YoY gain of 5825.24% in 2024, and its largest YoY loss of 9634.15% in 2024.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Depreciation & Amortization (CF) stood at $117000.0 in 2021, then decreased by 8.55% to $107000.0 in 2022, then soared by 53.27% to $164000.0 in 2023, then tumbled by 96.34% to $6000.0 in 2024, then grew by 16.67% to $7000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $7000.0 for Q3 2025, versus $6000.0 for Q2 2025 and $7000.0 for Q1 2025.